Clinical trial
A Phase 1 Study of E7130 in Subjects With Solid Tumor
NCT03444701 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of E7130 in Subjects With Solid Tumor
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 5, 2018
- Completion date
- December 27, 2024
- Enrollment
- 62 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumors